DK1416958T4 - Vaccinesammensætning, som indeholder mindst to valenser, én med adjuvans og én uden adjuvans - Google Patents

Vaccinesammensætning, som indeholder mindst to valenser, én med adjuvans og én uden adjuvans

Info

Publication number: DK1416958T4
Authority: DK; Denmark
Prior art keywords: valence; adjuvant; vaccine composition; valences; composition containing
Prior art date: 2001-08-08

Application number

DK02779603.6T

Other languages

English (en)

Other versions

DK1416958T3 (da

Inventor

Alain Francon

Original Assignee

Sanofi Pasteur

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-08

Filing date

2002-07-31

Publication date

2012-07-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8866367&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1416958(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-07-31 Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur

2007-07-30 Publication of DK1416958T3 publication Critical patent/DK1416958T3/da

2012-07-09 Application granted granted Critical

2012-07-09 Publication of DK1416958T4 publication Critical patent/DK1416958T4/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK02779603.6T 2001-08-08 2002-07-31 Vaccinesammensætning, som indeholder mindst to valenser, én med adjuvans og én uden adjuvans DK1416958T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0110573A FR2828406B1 (fr)	2001-08-08	2001-08-08	Composition vaccinale bivalente havi
PCT/FR2002/002770 WO2003013600A1 (fr)	2001-08-08	2002-07-31	Composition vaccinale comprenant au moins deux valances, l'une adjuvantee, l'autre pas

Publications (2)

Publication Number	Publication Date
DK1416958T3 DK1416958T3 (da)	2007-07-30
DK1416958T4 true DK1416958T4 (da)	2012-07-09

Family

ID=8866367

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02779603.6T DK1416958T4 (da)	2001-08-08	2002-07-31	Vaccinesammensætning, som indeholder mindst to valenser, én med adjuvans og én uden adjuvans

Country Status (22)

Country	Link
US (1)	US7404960B2 (da)
EP (1)	EP1416958B2 (da)
JP (1)	JP4221291B2 (da)
KR (1)	KR100881703B1 (da)
CN (1)	CN1282486C (da)
AT (1)	ATE357929T1 (da)
AU (1)	AU2002342949B2 (da)
BR (1)	BRPI0211151B8 (da)
CA (1)	CA2455406C (da)
CY (1)	CY1107619T1 (da)
DE (1)	DE60219177T3 (da)
DK (1)	DK1416958T4 (da)
ES (1)	ES2284940T5 (da)
FR (1)	FR2828406B1 (da)
HU (1)	HU228216B1 (da)
IL (2)	IL159519A0 (da)
MX (1)	MXPA04001125A (da)
NZ (1)	NZ530727A (da)
PL (1)	PL215134B1 (da)
PT (1)	PT1416958E (da)
WO (1)	WO2003013600A1 (da)
ZA (1)	ZA200400022B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2464522C (en)	2004-04-15	2011-11-15	Eng-Hong Lee	Soft gel delivery system for treating poultry
BRPI0716518B8 (pt) *	2006-09-07	2021-05-25	Glaxosmithkline Biologicals Sa	vacina de ipv e uso da mesma
KR101101901B1 (ko) *	2009-01-30	2012-01-02	주식회사 리노	주방용 선반
PT2411048T (pt)	2009-03-24	2020-07-14	Glaxosmithkline Biologicals Sa	Proteína de ligação ao fator h meningocócica com adjuvante
CN102526724B (zh) *	2011-01-14	2015-07-22	四川大学	氢氧化铝凝胶-多糖复合免疫佐剂及其制备方法和用途
FR2985663B1 (fr) *	2012-01-17	2015-03-27	Sanofi Pasteur	Procede de formulation d'un vaccin contenant au moins deux antigenes susceptibles de s'adsorber sur de l'oxy hydroxyde d'aluminium

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2734484B1 (fr) *	1995-05-24	1997-06-27	Pasteur Merieux Serums Vacc	Composition vaccinale liquide et procede de fabrication
GB9806456D0 (en) *	1998-03-25	1998-05-27	Smithkline Beecham Biolog	Vaccine composition
EP1285666A1 (en) *	1998-08-28	2003-02-26	SMITHKLINE BEECHAM BIOLOGICALS s.a.	Salmonella typhi vaccine compositions
US6585973B1 (en) *	1998-10-29	2003-07-01	Henry M. Jackson Foundation For The Advancement Of Military Medicine	Method for preparing solid phase conjugated vaccine
GB9909077D0 (en) *	1999-04-20	1999-06-16	Smithkline Beecham Biolog	Novel compositions

2001
- 2001-08-08 FR FR0110573A patent/FR2828406B1/fr not_active Expired - Lifetime
2002
- 2002-07-31 KR KR1020047001923A patent/KR100881703B1/ko active IP Right Grant
- 2002-07-31 MX MXPA04001125A patent/MXPA04001125A/es active IP Right Grant
- 2002-07-31 PL PL367904A patent/PL215134B1/pl unknown
- 2002-07-31 AU AU2002342949A patent/AU2002342949B2/en not_active Expired
- 2002-07-31 NZ NZ530727A patent/NZ530727A/en not_active IP Right Cessation
- 2002-07-31 JP JP2003518604A patent/JP4221291B2/ja not_active Expired - Lifetime
- 2002-07-31 PT PT02779603T patent/PT1416958E/pt unknown
- 2002-07-31 US US10/485,748 patent/US7404960B2/en not_active Expired - Lifetime
- 2002-07-31 ES ES02779603T patent/ES2284940T5/es not_active Expired - Lifetime
- 2002-07-31 EP EP02779603A patent/EP1416958B2/fr not_active Expired - Lifetime
- 2002-07-31 BR BRPI0211151-9 patent/BRPI0211151B8/pt not_active IP Right Cessation
- 2002-07-31 DK DK02779603.6T patent/DK1416958T4/da active
- 2002-07-31 AT AT02779603T patent/ATE357929T1/de active
- 2002-07-31 IL IL15951902A patent/IL159519A0/xx unknown
- 2002-07-31 HU HU0401182A patent/HU228216B1/hu unknown
- 2002-07-31 DE DE60219177T patent/DE60219177T3/de not_active Expired - Lifetime
- 2002-07-31 CN CNB028156455A patent/CN1282486C/zh not_active Expired - Lifetime
- 2002-07-31 CA CA2455406A patent/CA2455406C/en not_active Expired - Lifetime
- 2002-07-31 WO PCT/FR2002/002770 patent/WO2003013600A1/fr active IP Right Grant
2003
- 2003-12-22 IL IL159519A patent/IL159519A/en unknown
2004
- 2004-01-05 ZA ZA200400022A patent/ZA200400022B/en unknown
2007
- 2007-04-16 CY CY20071100521T patent/CY1107619T1/el unknown

Also Published As

Publication number	Publication date
EP1416958A1 (fr)	2004-05-12
CA2455406C (en)	2012-03-13
MXPA04001125A (es)	2004-05-20
ZA200400022B (en)	2006-05-31
NZ530727A (en)	2004-06-25
CN1541108A (zh)	2004-10-27
EP1416958B1 (fr)	2007-03-28
HUP0401182A2 (hu)	2004-09-28
PT1416958E (pt)	2007-05-31
US20040170648A1 (en)	2004-09-02
HU228216B1 (en)	2013-02-28
DE60219177D1 (de)	2007-05-10
HUP0401182A3 (en)	2004-10-28
FR2828406A1 (fr)	2003-02-14
BRPI0211151B8 (pt)	2021-05-25
FR2828406B1 (fr)	2005-06-24
WO2003013600A1 (fr)	2003-02-20
DK1416958T3 (da)	2007-07-30
PL367904A1 (en)	2005-03-07
ATE357929T1 (de)	2007-04-15
CA2455406A1 (en)	2003-02-20
KR100881703B1 (ko)	2009-02-06
IL159519A (en)	2010-11-30
US7404960B2 (en)	2008-07-29
KR20040043182A (ko)	2004-05-22
PL215134B1 (pl)	2013-10-31
BR0211151A (pt)	2004-08-10
JP2005501081A (ja)	2005-01-13
JP4221291B2 (ja)	2009-02-12
ES2284940T3 (es)	2007-11-16
AU2002342949B2 (en)	2007-07-05
CY1107619T1 (el)	2013-04-18
EP1416958B2 (fr)	2012-03-14
BRPI0211151B1 (pt)	2019-07-09
CN1282486C (zh)	2006-11-01
DE60219177T3 (de)	2012-08-30
ES2284940T5 (es)	2012-07-02
DE60219177T2 (de)	2008-01-24
IL159519A0 (en)	2004-06-01

Publication	Publication Date	Title
DK0777490T3 (da)	2006-09-18	Mutant-enterotoxin, som er effektivt som et ikke-toksisk oralt adjuvans
ES2113882T3 (es)	1998-05-16	Vacuna oral que comprende un antigeno asociado superficialmente con eritrocitos.
SE7613851L (sv)	1977-06-11	Glukosaminderivat
UY26801A1 (es)	2002-01-31	Composición de vacuna
DE60238471D1 (de)	2011-01-13	Proteosom-liposaccharid-vakzine-adjuvans
FI931169A0 (fi)	1993-03-16	Foerbaettrade vaccinkompositioner
DK1416958T4 (da)	2012-07-09	Vaccinesammensætning, som indeholder mindst to valenser, én med adjuvans og én uden adjuvans
DE69527986D1 (de)	2002-10-02	Antigene arznei zur behandlung oder vorbeugung
SE9904581D0 (sv)	1999-12-15	A novel helicobacter pylori-binding substance and use thereof
EE200100597A (et)	2003-02-17	Antigeenne kompositsioon kombinatsioonis adjuvantidega ning meetod selle toimetõhususe suurendamiseks
DK76191D0 (da)	1991-04-25	Filamentoest haemagglutinin fra b.pertussis
BR0111488A (pt)	2003-03-25	Recurso de tampão
DE60005164D1 (de)	2003-10-16	Verwendung von fucosilierten sialilierten n-acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion
BR0011478A (pt)	2002-03-19	Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal
WO2003049670A3 (en)	2003-11-06	Adjuvant formulations for bacterial and virus vaccines and method of making same
EA200200704A1 (ru)	2003-08-28	Ослабленные микроорганизмы для лечения инфекции
JPS5346712A (en)	1978-04-26	Magnetic memory device
FI864769A (fi)	1986-11-24	Icke-adjuvanserad vaccin.
ITVA20020058A1 (it)	2004-05-16	Composizioni di pvc stabili al calore.
BRMU8402867U (pt)	2006-07-04	escova descartável - combate